• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Stocks That Hit 52-Week Lows On Wednesday

    2/8/23 1:45:50 PM ET
    $ALLR
    $ASST
    $ASTI
    $AUID
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $ALLR alert in real time by email

     

    On Wednesday, 20 companies achieved new lows for the year.

    52-Week Low Highlights:

    • Jack Henry & Associates (NASDAQ:JKHY) was the largest firm by market cap to set a new 52-week low.
    • The smallest company by market cap to set a new 52-week low was Edible Garden (NASDAQ:EDBL).
    • Titan Medical (NASDAQ:TMDI)'s stock dropped the most, trading down 70.69% to reach a new 52-week low.
    • TIM (NYSE:TIMB) was the biggest winner of the bunch, with shares actually trading up 0.19% after it rebounded from its new 52-week low.

    On Wednesday, the following stocks hit new 52-week lows:

    • Jack Henry & Associates (NASDAQ:JKHY) shares set a new 52-week low of $164.00. The stock traded down 9.0%.
    • TIM (NYSE:TIMB) shares set a new 52-week low of $10.48. The stock traded up 0.19%.
    • Lumen Technologies (NYSE:LUMN) stock drifted down 19.04% on Wednesday morning to hit a new 52-week low of $3.90.
    • Freightos (NASDAQ:CRGO) shares set a new 52-week low of $6.50. The stock traded down 6.25%.
    • Semler Scientific (NASDAQ:SMLR) stock hit $21.21 on Wednesday morning, setting a new 52-week low for a change of down 6.73%.
    • Mastech Digital (AMEX:MHH) shares reached a new 52-week low of $10.70 on Wednesday morning, moving down 14.87%.
    • BM Technologies (AMEX:BMTX) shares made a new 52-week low of $4.25 on Wednesday. The stock was down 1.39% for the day.
    • Ascent Solar Technologies (NASDAQ:ASTI) shares set a new 52-week low of $0.89. The stock traded down 15.07%.
    • Asset Entities (NASDAQ:ASST) stock hit $2.29 on Wednesday morning, setting a new 52-week low for a change of down 2.06%.
    • Titan Medical (NASDAQ:TMDI) shares fell to $0.23 on Wednesday, setting a new 52-week low with a shift of down 70.69%.
    • MGO Global (NASDAQ:MGOL) shares were down 4.18% for the day, having made a 52-week low of $2.02.
    • Cadrenal Therapeutics (NASDAQ:CVKD) stock dropped to a yearly low on Wednesday of $2.04. Shares traded down 5.56%.
    • Smart Powerr (NASDAQ:CREG) shares set a new yearly low of $1.80 this morning. The stock was down 2.42% on the session.
    • AuthID (NASDAQ:AUID) shares hit a yearly low of $0.43. The stock was down 4.95% on the session.
    • Revelation Biosciences (NASDAQ:REVB) shares set a new yearly low of $5.79 this morning. The stock was down 8.3% on the session.
    • Tenax Therapeutics (NASDAQ:TENX) shares moved down 10.74% on Wednesday to hit a new 52-week low of $1.31, drifting down 10.74%.
    • Allarity Therapeutics (NASDAQ:ALLR) stock broke to a new 52-week low of $0.19 on Wednesday. Shares of the company traded down 7.11%.
    • SINTX Technologies (NASDAQ:SINT) stock achieved a new 52-week low on Wednesday morning, hitting $3.23 and moving down 43.43%.
    • Edible Garden (NASDAQ:EDBL) stock achieved a new 52-week low on Wednesday morning, hitting $4.25 and moving down 8.33%.

    Be sure to stay with Benzinga for further updates and market-moving news. And if you want to be among the first to know about the 52-week highs and lows for the day, check out Benzinga Pro. Users receive a daily alert listing stocks trading near 52-week highs and lows each morning. Click here to learn more.

    Get the next $ALLR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLR
    $ASST
    $ASTI
    $AUID

    CompanyDatePrice TargetRatingAnalyst
    Jack Henry & Associates Inc.
    $JKHY
    11/20/2025$198.00Mkt Perform → Strong Buy
    Raymond James
    Jack Henry & Associates Inc.
    $JKHY
    11/6/2025$187.00Neutral → Buy
    Compass Point
    TIM S.A.
    $TIMB
    11/5/2025Sector Outperform → Sector Perform
    Scotiabank
    TIM S.A.
    $TIMB
    11/5/2025$27.00Hold → Buy
    HSBC Securities
    Lumen Technologies Inc.
    $LUMN
    10/31/2025$11.00Buy → Neutral
    Citigroup
    Jack Henry & Associates Inc.
    $JKHY
    10/22/2025$161.00Equal Weight
    Wells Fargo
    TIM S.A.
    $TIMB
    9/10/2025Buy
    Citigroup
    Tenax Therapeutics Inc.
    $TENX
    9/8/2025$20.00Overweight
    Piper Sandler
    More analyst ratings

    $ALLR
    $ASST
    $ASTI
    $AUID
    SEC Filings

    View All

    Amendment: SEC Form S-4/A filed by Strive Inc.

    S-4/A - Strive, Inc. (0001920406) (Filer)

    12/3/25 5:12:55 PM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    Revelation Biosciences Inc. filed SEC Form 8-K: Material Modification to Rights of Security Holders, Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    8-K - REVELATION BIOSCIENCES, INC. (0001810560) (Filer)

    12/3/25 5:01:56 PM ET
    $REVB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form S-3 filed by Allarity Therapeutics Inc.

    S-3 - Allarity Therapeutics, Inc. (0001860657) (Filer)

    12/3/25 9:11:40 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $ASST
    $ASTI
    $AUID
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Golden Lee Scott

    4 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    12/3/25 8:08:16 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    New insider Golden Lee Scott claimed ownership of 1,667 shares (SEC Form 3)

    3 - Cadrenal Therapeutics, Inc. (0001937993) (Issuer)

    12/3/25 8:07:37 PM ET
    $CVKD
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Foss David B sold $3,498,400 worth of shares (20,000 units at $174.92), decreasing direct ownership by 14% to 128,133 units (SEC Form 4)

    4 - JACK HENRY & ASSOCIATES INC (0000779152) (Issuer)

    12/3/25 12:30:46 PM ET
    $JKHY
    EDP Services
    Technology

    $ALLR
    $ASST
    $ASTI
    $AUID
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ascent Solar Technologies Provides Leading Space Company with Thin-Film PV modules for Spacecraft Power Generation Testing in Cislunar Space

    THORNTON, Colo., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Ascent Solar Technologies ("Ascent"), the leading U.S. innovator in the design and manufacturing of featherweight, flexible thin-film photovoltaic (PV) solutions, today announced that it recently provided test modules of its thin-film PV technology to a leading space company. The modules are currently being tested on their ability to generate power for spacecraft in Cislunar space, the region of space between the Earth and the moon. Preliminary findings from these tests have shown promising results for the technology's capabilities. Reaching the moon requires significantly more energy than achieving low Earth orbit for space vehicles. As

    12/3/25 8:00:00 AM ET
    $ASTI
    Semiconductors
    Technology

    Lumen Renews Signature Teachers & Technology Grant Program with $1 Million for Classroom Innovation

    Coinciding with Giving Tuesday, application period is open through Jan. 15, 2026 for teachers in 10 states Lumen Technologies (NYSE: LUMN) today announced the latest round of its long-standing Teachers and Technology grant program, committing $1 million in new funding to help K-12 educators bring innovative technology into their classrooms. Through the Lumen Clarke M. Williams Foundation, individual grants of up to $5,000 will be awarded to schools in 10 states to purchase technology that equips students with the digital skills needed for success today and in an AI-driven future. "At Lumen, we're proud of our long-standing commitment to building partnerships in communities where our emplo

    12/2/25 9:15:00 AM ET
    $LUMN
    Telecommunications Equipment
    Telecommunications

    Edible Garden to Feature Hydroponic Basil, Pulp, and Pickle Party® at the NY Produce Show at the Jacob Javits Center in New York City on December 3

    BELVIDERE, NJ, Dec. 02, 2025 (GLOBE NEWSWIRE) -- Edible Garden AG Incorporated ("Edible Garden" or the "Company") (NASDAQ:EDBL, EDBLW), EDBLW), a leading provider of controlled environment agriculture (CEA) solutions and sustainable, locally grown organic produce, today announced that it will participate in the 2025 New York Produce Show and Conference, taking place December 3, 2025, at the Jacob Javits Center in New York City. At the event, the Company will showcase its Hydroponic Basil, along with its rapidly expanding Pulp fermented sauces and Pickle Party® fresh fermented product lines. The New York Produce Show and Conference is one of the fresh produce industry's most influential an

    12/2/25 9:15:00 AM ET
    $EDBL
    Farming/Seeds/Milling
    Consumer Staples

    $ALLR
    $ASST
    $ASTI
    $AUID
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Jisser Ken bought $50,406 worth of shares (40,650 units at $1.24), increasing direct ownership by 79% to 92,125 units (SEC Form 4)

    4 - authID Inc. (0001534154) (Issuer)

    11/26/25 8:00:31 AM ET
    $AUID
    Computer Software: Prepackaged Software
    Technology

    Director Garchik Stephen Jeffrey bought $216,500 worth of shares (126,608 units at $1.71) (SEC Form 4)

    4 - authID Inc. (0001534154) (Issuer)

    11/24/25 4:10:09 PM ET
    $AUID
    Computer Software: Prepackaged Software
    Technology

    CEO Giordano Christopher Thomas bought $20,000 worth of shares (2,605 units at $7.68) (SEC Form 4)

    4 - TENAX THERAPEUTICS, INC. (0000034956) (Issuer)

    11/20/25 6:38:51 PM ET
    $TENX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $ASST
    $ASTI
    $AUID
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Jack Henry upgraded by Raymond James with a new price target

    Raymond James upgraded Jack Henry from Mkt Perform to Strong Buy and set a new price target of $198.00

    11/20/25 7:57:27 AM ET
    $JKHY
    EDP Services
    Technology

    Jack Henry upgraded by Compass Point with a new price target

    Compass Point upgraded Jack Henry from Neutral to Buy and set a new price target of $187.00

    11/6/25 8:40:16 AM ET
    $JKHY
    EDP Services
    Technology

    TIM S.A. downgraded by Scotiabank

    Scotiabank downgraded TIM S.A. from Sector Outperform to Sector Perform

    11/5/25 3:17:58 PM ET
    $TIMB
    Telecommunications Equipment
    Telecommunications

    $ALLR
    $ASST
    $ASTI
    $AUID
    Leadership Updates

    Live Leadership Updates

    View All

    Cadrenal Therapeutics Appoints Dr. Lee Golden to Board of Directors

    PONTE VEDRA, Fla., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Cadrenal Therapeutics, Inc. (NASDAQ:CVKD), a biopharmaceutical company developing transformative therapeutics to overcome current gaps in anticoagulation therapy, today announced the appointment of Lee Scott Golden, M.D., to its Board of Directors, effective immediately. Dr. Golden will serve as an independent director. Dr. Golden currently serves as Executive Vice President and Chief Medical Officer at PTC Therapeutics, Inc. (NASDAQ:PTCT), where he leads global clinical development across a broad rare disease pipeline. Before joining PTC, Dr. Golden served as the Chief Medical Officer at Espero BioPharma, Inc., a development-stage card

    12/1/25 9:00:00 AM ET
    $CVKD
    $PTCT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Freightos appoints Michael Netter as CRO to Drive Global Go-to-Market Strategy

    Digital Logistics Expert Brings Proven Logistics Tech Experience to Drive Expansion Across the Freight Ecosystem BARCELONA, Spain, Nov. 10, 2025 /PRNewswire/ -- Freightos Limited (NASDAQ:CRGO), the leading digital freight booking and payment platform for the international freight industry, today announced the appointment of Michael Netter as Chief Revenue Officer (CRO). Netter will lead global revenue strategy, sales excellence and commercial execution. Netter brings deep experience in B2B SaaS, digital logistics, IoT solutions and Go-To-Market leadership. This includes his most recent role as Vice President of Sales EMEA at Proemion, an IoT and Industry 4.0 software company.  Prior to that

    11/10/25 7:00:00 AM ET
    $CRGO
    Integrated Freight & Logistics
    Industrials

    David Foss, Former President and CEO of Jack Henry, Appointed to WEX Board of Directors

    WEX (NYSE:WEX), the global commerce platform that simplifies the business of running a business, today announced that David Foss has been appointed to its Board of Directors, effective November 3, 2025. Mr. Foss's appointment is the result of an extensive search process with the assistance of an independent recruitment firm. Mr. Foss brings over 30 years of leadership experience in financial services and financial technology to WEX, most recently as Chief Executive Officer of Jack Henry & Associates (NASDAQ:JKHY). He also has relevant public company board experience, currently serving as Chair of Jack Henry and as a Director of CNO Financial Group (NYSE:CNO). "We are pleased to welcome

    10/29/25 4:30:00 PM ET
    $CNO
    $JKHY
    $WEX
    Accident &Health Insurance
    Finance
    EDP Services
    Technology

    $ALLR
    $ASST
    $ASTI
    $AUID
    Financials

    Live finance-specific insights

    View All

    QVC Group Announces Semi-Annual Interest Payment and Regular Additional Distribution on 4.0% Senior Exchangeable Debentures Due 2029

    WEST CHESTER, Pa., Nov. 17, 2025 /PRNewswire/ -- QVC Group, Inc. ("QVC Group")  (NASDAQ:QVCGA, QVCGP, OTCQB:QVCGB) today announced the payment of a semi-annual interest payment and Regular Additional Distribution to the holders as of Nov 1, 2025 of the 4.0% Senior Exchangeable Debentures due 2029 (the "Debentures") issued by its wholly-owned subsidiary, Liberty Interactive LLC ("LI LLC"). The semi-annual interest payment amount is $20.00 per $1,000 original principal amount of Debentures (a "Debenture"), and the amount of the Regular Additional Distribution is $0.5824 per $1,000 original principal amount of Debentures.

    11/17/25 4:59:00 PM ET
    $LUMN
    $QVCGA
    $QVCGB
    Telecommunications Equipment
    Telecommunications
    Catalog/Specialty Distribution
    Consumer Discretionary

    Freightos Reports Third Quarter 2025 Results

    Third quarter revenue up 24% year-over-year Reached annualized run rate of over 1.7 million transactions and $1.3B GBV BARCELONA, Spain, Nov. 17, 2025 /PRNewswire/ --  Freightos Limited (NASDAQ:CRGO), the leading vendor-neutral digital booking and payment platform for the international freight industry, today reported its financial results for the quarter ended September 30, 2025. "This quarter marks another consecutive period of record revenue and transactions for Freightos as we continue to demonstrate the resilience and growing adoption of our digital freight booking platform," said Zvi Schreiber, CEO of Freightos. "Our results show how freight rate volatility is accelerating the industr

    11/17/25 7:00:00 AM ET
    $CRGO
    Integrated Freight & Logistics
    Industrials

    Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates

         Received FDA Fast Track designation for stenoparib in advanced ovarian cancer Reported landmark median overall survival now exceeding 25 months in ongoing Phase 2 trialAdvanced DRP® platform through new licensing agreement TARPON SPRINGS, Fla., November 14, 2025 – Allarity Therapeutics, Inc. ("Allarity" or the "Company") (NASDAQ:ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a differentiated, dual PARP and WNT pathway inhibitor—today reported financial results and provided an update on operational highlights for the third quarter ended September 30, 2025. "The third quarter of 2025 was another milestone period for Allarity as we ac

    11/14/25 9:00:00 AM ET
    $ALLR
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLR
    $ASST
    $ASTI
    $AUID
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Semler Scientific Inc.

    SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)

    12/12/24 4:16:00 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by Semler Scientific Inc.

    SC 13G - Semler Scientific, Inc. (0001554859) (Subject)

    11/26/24 12:09:40 PM ET
    $SMLR
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    11/14/24 7:25:52 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care